SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review
JAC Nascimento Junior, AM Santos… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Coronavirus has been responsible for several virus outbreaks since 2003,
caused by SARS-CoV-1, MERS-CoV, and currently SARS-CoV-2 (COVID-19), the causative …
caused by SARS-CoV-1, MERS-CoV, and currently SARS-CoV-2 (COVID-19), the causative …
Treatment of SARS-CoV-2: How far have we reached?
The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently
affecting more than 200 countries and territories worldwide. It has been declared as …
affecting more than 200 countries and territories worldwide. It has been declared as …
Efficacy and safety of current therapeutic options for COVID-19-lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
H Zhong, Y Wang, ZL Zhang, YX Liu, KJ Le… - Pharmacological …, 2020 - Elsevier
The rapidly progressing of coronavirus disease 2019 (COVID-19) pandemic has become a
global concern. This meta-analysis aimed at evaluating the efficacy and safety of current …
global concern. This meta-analysis aimed at evaluating the efficacy and safety of current …
Treatment options for COVID-19: a review
Background: The recent COVID-19 pandemic sweeping the globe has caused great concern
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …
SARS-CoV-2 therapeutics: how far do we stand from a remedy?
The SARS-CoV-2 has affected millions worldwide and has posed an immediate need for
effective pharmacological interventions. Ever since the outbreak was declared, the medical …
effective pharmacological interventions. Ever since the outbreak was declared, the medical …
[HTML][HTML] An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics
D Wang, Z Li, Y Liu - Journal of infection and public health, 2020 - Elsevier
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
Literature-based review of the drugs used for the treatment of COVID-19
M Venkatasubbaiah, PD Reddy… - … medicine research and …, 2020 - Elsevier
COVID-19 is primarily a respiratory disease caused by a newly discovered SARS-CoV-2
virus and identified in the city of Wuhan, China in December 2019. WHO has declared this …
virus and identified in the city of Wuhan, China in December 2019. WHO has declared this …
Advances in the possible treatment of COVID-19: A review.
P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
SARS-coV-2 treatment approaches: numerous options, no certainty for a versatile virus
S Iacob, DG Iacob - Frontiers in Pharmacology, 2020 - frontiersin.org
SARS-CoV-2 is the most recent coronavirus which crossed the species barrier in 2019 and
provoked a still ongoing and dangerous pandemic known as coronavirus disease 2019 …
provoked a still ongoing and dangerous pandemic known as coronavirus disease 2019 …
Current targeted therapeutics against COVID-19: based on first-line experience in China
Y Zhang, Q Xu, Z Sun, L Zhou - Pharmacological research, 2020 - Elsevier
SARS-CoV-2 is a novel strain, causing a global pandemic since the end of 2019. The
majority of patients showed nonspecific symptoms such as fever, dry cough, and fatigue …
majority of patients showed nonspecific symptoms such as fever, dry cough, and fatigue …